Placental vitamin D receptor expression is decreased in human idiopathic fetal growth restriction

Journal of Molecular Medicine

Volumn 93, Issue 7, 2015, Pages 795-805

  Nguyen, T P H ^a,b   Yong, H E J ^a,b   Chollangi, T ^a,b   Borg, A J ^a,b   Brennecke, S P ^a,b   Murthi, P ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

Differentiation; Fetal growth restriction; Placenta; Trophoblast; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CHORIONIC GONADOTROPIN BETA SUBUNIT; MESSENGER RNA; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; SMALL INTERFERING RNA; VITAMIN D;

ABDOMINAL CIRCUMFERENCE; ADULT; APOPTOSIS; ARTICLE; BIRTH WEIGHT; CELL ADHESION; CELL DIFFERENTIATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; HEAD CIRCUMFERENCE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTRAUTERINE GROWTH RETARDATION; MALE; MATERNAL AGE; NEWBORN; OLIGOHYDRAMNIOS; PARITY; PLACENTA; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST; TROPHOBLAST; BIOSYNTHESIS; CYTOLOGY; FETUS DEVELOPMENT; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; RNA INTERFERENCE; TUMOR CELL LINE;

APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; HUMANS; MALE; PLACENTA; PREGNANCY; RECEPTORS, CALCITRIOL; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TROPHOBLASTS; VITAMIN D;

EID: 84931567069     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-015-1267-1     Document Type: Article

References (68)

1. Bikle DD (2011) Vitamin D regulation of immune function. Vitam Horm 86:1–21
2. Lagishetty V, Liu NQ, Hewison M (2011) Vitamin D metabolism and innate immunity. Mol Cell Endocrinol 347:97–105
3. Wei SQ, Qi HP, Luo ZC, Fraser WD (2013) Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis. J J Matern Fetal Neonatal Med Off J Eur Assoc Perinatal Med Fed Asia Ocean Perinatal Soc Int Soc Perinatal Obstet 26:889–899
4. Robinson CJ, Wagner CL, Hollis BW, Baatz JE, Johnson DD (2011) Maternal vitamin D and fetal growth in early-onset severe preeclampsia. Am J Obstet Gynecol 204(556):e551–554
5. Kumar R, Cohen WR, Silva P, Epstein FH (1979) Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. J Clin Invest 63:342–344
6. Liu NQ, Hewison M (2012) Vitamin D, the placenta and pregnancy. Arch Biochem Biophys 523:37–47
7. Robinson CJ, Alanis MC, Wagner CL, Hollis BW, Johnson DD (2010) Plasma 25-hydroxyvitamin D levels in early-onset severe preeclampsia. Am J Obstet Gynecol 203(366):e361–366
8. Thorne-Lyman A, Fawzi WW (2012) Vitamin D during pregnancy and maternal, neonatal and infant health outcomes: a systematic review and meta-analysis. Paediatr Perinat Epidemiol 26(Suppl 1):75–90
9. De-Regil LM, Palacios C, Ansary A, Kulier R, Pena-Rosas JP (2012) Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev 2:CD008873
10. Goyal R, Zhang L, Blood AB, Baylink DJ, Longo LD, Oshiro B, Mata-Greenwood E (2014) Characterization of an animal model of pregnancy-induced vitamin D deficiency due to metabolic gene dysregulation. Am J Physiol Endocrinol Metab 306:E256–266
11. Awad AB, Alappat L, Valerio M (2012) Vitamin d and metabolic syndrome risk factors: evidence and mechanisms. Crit Rev Food Sci Nutr 52:103–112
12. Fleet JC, DeSmet M, Johnson R, Li Y (2012) Vitamin D and cancer: a review of molecular mechanisms. Biochem J 441:61–76
13. Motiwala SR, Wang TJ (2011) Vitamin D and cardiovascular disease. Curr Opin Nephrol Hypertens 20:345–353
14. Ponsonby AL, Lucas RM, Lewis S, Halliday J (2010) Vitamin D status during pregnancy and aspects of offspring health. Nutrients 2:389–407
15. Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, Shoenfeld Y, Lerchbaum E, Llewellyn DJ, Kienreich K et al (2013) Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev 12:976–989
16. McIntire DD, Bloom SL, Casey BM, Leveno KJ (1999) Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 340:1234–1238
17. Scifres CM, Nelson DM (2009) Intrauterine growth restriction, human placental development and trophoblast cell death. J Physiol 587:3453–3458
18. Mongelli M, Gardosi J (2000) Fetal growth. Curr Opin Obstet Gynecol 12:111–115
19. Godfrey KM, Barker DJ (2001) Fetal programming and adult health. Public Health Nutr 4:611–624
20. Barker DJ, Eriksson JG, Forsen T, Osmond C (2002) Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 31:1235–1239
21. Steffensen FH, Sorensen HT, Gillman MW, Rothman KJ, Sabroe S, Fischer P, Olsen J (2000) Low birth weight and preterm delivery as risk factors for asthma and atopic dermatitis in young adult males. Epidemiology 11:185–188
22. Rosso IM, Cannon TD, Huttunen T, Huttunen MO, Lonnqvist J, Gasperoni TL (2000) Obstetric risk factors for early-onset schizophrenia in a Finnish birth cohort. Am J Psychiatry 157:801–807
23. Gale CR, Martyn CN (2004) Birth weight and later risk of depression in a national birth cohort. Br J Psychiatry 184:28–33
24. Frisk V, Amsel R, Whyte HE (2002) The importance of head growth patterns in predicting the cognitive abilities and literacy skills of small-for-gestational-age children. Dev Neuropsychol 22:565–593
25. Sankaran S, Kyle PM (2009) Aetiology and pathogenesis of IUGR. Best Pract Res Clin Obstet Gynaecol 23:765–777
26. Handwerger S (2010) New insights into the regulation of human cytotrophoblast cell differentiation. Mol Cell Endocrinol 323:94–104
27. Ma R, Gu Y, Zhao S, Sun J, Groome LJ, Wang Y (2012) Expressions of vitamin D metabolic components VDBP, CYP2R1, CYP27B1, CYP24A1, and VDR in placentas from normal and preeclamptic pregnancies. Am J Physiol Endocrinol Metab 303:E928–935
28. Murthi P, Said JM, Doherty VL, Donath S, Nowell CJ, Brennecke SP, Kalionis B (2006) Homeobox gene DLX4 expression is increased in idiopathic human fetal growth restriction. Mol Hum Reprod 12:763–769
29. Murthi P, Doherty VL, Said JM, Donath S, Brennecke SP, Kalionis B (2006) Homeobox gene ESX1L expression is decreased in human pre-term idiopathic fetal growth restriction. Mol Hum Reprod 12:335–340
30. Murthi P, Doherty V, Said J, Donath S, Brennecke SP, Kalionis B (2006) Homeobox gene HLX1 expression is decreased in idiopathic human fetal growth restriction. Am J Pathol 168:511–518
31. Rajaraman G, Murthi P, Leo B, Brennecke SP, Kalionis B (2007) Homeobox gene HLX1 is a regulator of colony stimulating factor-1 dependent trophoblast cell proliferation. Placenta 28:991–998
32. Rajaraman G, Murthi P, Pathirage N, Brennecke SP, Kalionis B (2010) Downstream targets of homeobox gene HLX show altered expression in human idiopathic fetal growth restriction. Am J Pathol 176:278–287
33. Pathirage NA, Cocquebert M, Sadovsky Y, Abumaree M, Manuelpillai U, Borg A, Keogh RJ, Brennecke SP, Evain-Brion D, Fournier T et al (2013) Homeobox gene transforming growth factor beta-induced factor-1 (TGIF-1) is a regulator of villous trophoblast differentiation and its expression is increased in human idiopathic fetal growth restriction. Mol Hum Reprod 19:665–675
34. Guaran RL, Wein P, Sheedy M, Walstab J, Beischer NA (1994) Update of growth percentiles for infants born in an Australian population. Aust N Z J Obstet Gynaecol 34:39–50
35. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101–1108
36. Keogh RJ (2010) New technology for investigating trophoblast function. Placenta 31:347–350
37. Chen CP, Bajoria R, Aplin JD (2002) Decreased vascularization and cell proliferation in placentas of intrauterine growth-restricted fetuses with abnormal umbilical artery flow velocity waveforms. Am J Obstet Gynecol 187:764–769
38. Kingdom J, Huppertz B, Seaward G, Kaufmann P (2000) Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol 92:35–43
39. Avila E, Diaz L, Halhali A, Larrea F (2004) Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase, 1,25-dihydroxyvitamin D3 24-hydroxylase and vitamin D receptor gene expression by 8-bromo cyclic AMP in cultured human syncytiotrophoblast cells. J Steroid Biochem Mol Biol 89–90:115–119
40. Barrera D, Avila E, Hernandez G, Mendez I, Gonzalez L, Halhali A, Larrea F, Morales A, Diaz L (2008) Calcitriol affects hCG gene transcription in cultured human syncytiotrophoblasts. Reprod Biol Endocrinol RB&E 6:3
41. Stephanou A, Ross R, Handwerger S (1994) Regulation of human placental lactogen expression by 1,25-dihydroxyvitamin D3. Endocrinology 135:2651–2656
42. Tuan RS, Moore CJ, Brittingham JW, Kirwin JJ, Akins RE, Wong M (1991) In vitro study of placental trophoblast calcium uptake using JEG-3 human choriocarcinoma cells. J Cell Sci 98(Pt 3):333–342
43. Kovacs CS, Kronenberg HM (1997) Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 18:832–872
44. Evans KN, Bulmer JN, Kilby MD, Hewison M (2004) Vitamin D and placental-decidual function. J Soc Gynecol Investig 11:263–271
45. Kovacs CS (2008) Vitamin D in pregnancy and lactation: maternal, fetal, and neonatal outcomes from human and animal studies. Am J Clin Nutr 88:520S–528S
46. Zehnder D, Evans KN, Kilby MD, Bulmer JN, Innes BA, Stewart PM, Hewison M (2002) The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua. Am J Pathol 161:105–114
47. Samuel S, Sitrin MD (2008) Vitamin D’s role in cell proliferation and differentiation. Nutr Rev 66:S116–124
48. Shahbazi M, Jeddi-Tehrani M, Zareie M, Salek-Moghaddam A, Akhondi MM, Bahmanpoor M, Sadeghi MR, Zarnani AH (2011) Expression profiling of vitamin D receptor in placenta, decidua and ovary of pregnant mice. Placenta 32:657–664
49. Sandovici I, Hoelle K, Angiolini E, Constancia M (2012) Placental adaptations to the maternal-fetal environment: implications for fetal growth and developmental programming. Reprod Biomed Online 25:68–89
50. Novakovic B, Sibson M, Ng HK, Manuelpillai U, Rakyan V, Down T, Beck S, Fournier T, Evain-Brion D, Dimitriadis E et al (2009) Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J Biol Chem 284:14838–14848
51. Saffery R, Ellis J, Morley R (2009) A convergent model for placental dysfunction encompassing combined sub-optimal one-carbon donor and vitamin D bioavailability. Med Hypotheses 73:1023–1028
52. Jurutka PW, Whitfield GK, Hsieh JC, Thompson PD, Haussler CA, Haussler MR (2001) Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev Endocr Metab Disord 2:203–216
53. Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, Haussler CA, Galligan MA, Thatcher ML, Encinas Dominguez C et al (2001) Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 177:145–159
54. Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA (1997) Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89:166–170
55. Niimi T, Tomita H, Sato S, Kawaguchi H, Akita K, Maeda H, Sugiura Y, Ueda R (1999) Vitamin D receptor gene polymorphism in patients with sarcoidosis. Am J Respir Crit Care Med 160:1107–1109
56. Morley R, Carlin JB, Pasco JA, Wark JD, Ponsonby AL (2009) Maternal 25-hydroxyvitamin D concentration and offspring birth size: effect modification by infant VDR genotype. Eur J Clin Nutr 63:802–804
57. Kaufmann P, Black S, Huppertz B (2003) Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 69:1–7
58. Crocker IP, Cooper S, Ong SC, Baker PN (2003) Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol 162:637–643
59. Newhouse SM, Davidge ST, Winkler-Lowen B, Demianczuk N, Guilbert LJ (2007) In vitro differentiation of villous trophoblasts from pregnancies complicated by intrauterine growth restriction with and without pre-eclampsia. Placenta 28:999–1003
60. Huppertz B (2003) Extravillous trophoblast: proliferation and invasion during pregnancy. Pathologica 95:231–232
61. Mi S, Lee X, Li X, Veldman GM, Finnerty H, Racie L, LaVallie E, Tang XY, Edouard P, Howes S et al (2000) Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403:785–789
62. Vargas A, Moreau J, Le Bellego F, Lafond J, Barbeau B (2008) Induction of trophoblast cell fusion by a protein tyrosine phosphatase inhibitor. Placenta 29:170–174
63. Frendo JL, Cronier L, Bertin G, Guibourdenche J, Vidaud M, Evain-Brion D, Malassine A (2003) Involvement of connexin 43 in human trophoblast cell fusion and differentiation. J Cell Sci 116:3413–3421
64. Evseenko DA, Murthi P, Paxton JW, Reid G, Emerald BS, Mohankumar KM, Lobie PE, Brennecke SP, Kalionis B, Keelan JA (2007) The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction. FASEB J 21:3592–3605
65. Yung HW, Hemberger M, Watson ED, Senner CE, Jones CP, Kaufman RJ, Charnock-Jones DS, Burton GJ (2012) Endoplasmic reticulum stress disrupts placental morphogenesis: implications for human intrauterine growth restriction. J Pathol 228:554–564
66. Lala PK, Lee BP, Xu G, Chakraborty C (2002) Human placental trophoblast as an in vitro model for tumor progression. Can J Physiol Pharmacol 80:142–149
67. Huppertz B, Kadyrov M, Kingdom JC (2006) Apoptosis and its role in the trophoblast. Am J Obstet Gynecol 195:29–39
68. Smith SC, Baker PN (1999) Placental apoptosis is increased in post-term pregnancies. Br J Obstet Gynaecol 106:861–862